ImmunoGen, Inc.

During its first quarter sales and earnings call on 25 April, AbbVie CEO Robert Michael expressed confidence that the company can weather the current tariffs introduced by the Trump Administration as

There’s a lot going on in the external operating environment for contract development and manufacturing organization (CDMOs) and firms like Syngene International Ltd. are navigating the turbulence r

Henlius Biotech’s Hetronifly (serplulimab) could soon be authorized for use in EU patients with extensive-stage small cell lung cancer (ES-SCLC) after the European Medicines Agency’s human medicine ad

Pfizer , Henlius Biotech and ImmunoGen could this week learn whether the European Medicines Agency will recommend in favor of pan-EU marketing authorization for their respective orphan drugs, marsta